Back to Results
First PageMeta Content
Medicine / 73rd United States Congress / United States Securities and Exchange Commission / United States securities law / Pharmaceuticals policy / Prescription Drug User Fee Act / NASDAQ / Securities Exchange Act / Securities Act / Food and Drug Administration / Pharmaceutical sciences / Pharmacology


SEC Complaint: Cheng Yi Liang et al.
Add to Reading List

Document Date: 2011-03-29 14:12:36

Open Document

File Size: 158,63 KB

Share Result on Facebook
UPDATE